The roles of the new negative T cell costimulatory pathways in regulating autoimmunity

Immunity

Volumn 20, Issue 5, 2004, Pages 529-538

  Khoury, Samia J ^a   Sayegh, Mohamed H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INDUCIBLE COSTIMULATORY RECEPTOR; INTERLEUKIN 10; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PHORBOL MYRISTATE; PHOSPHOTYROSINE; PROGRAMMED DEATH RECEPTOR 1; PROGRAMMED DEATH RECEPTOR L; TYROSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; AUTOIMMUNITY; B LYMPHOCYTE; CANCER CELL; CANCER INVASION; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL HYBRIDIZATION; CELL LINE; CELL PROLIFERATION; DENDRITIC CELL; DIABETES MELLITUS; DIMERIZATION; DISEASE SEVERITY; HUMAN; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; IMMUNOREGULATION; LUNG CANCER; MACROPHAGE; MONOCYTE; MOUSE STRAIN; NONHUMAN; OVARY CANCER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE; TUMOR IMMUNITY; UPREGULATION;

ANIMALS; ANTIGENS, CD80; ANTIGENS, SURFACE; AUTOIMMUNITY; HUMANS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 2442461055     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(04)00116-5     Document Type: Review

References (84)

1. Agata Y., Kawasaki A., Nishimura H., Ishida Y., Tsubata T., Yagita H., Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8:1996;765-772
2. Akbari O., Freeman G.J., Meyer E.H., Greenfield E.A., Chang T.T., Sharpe A.H., Berry G., DeKruyff R.H., Umetsu D.T. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8:2002;1024-1032
3. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., Yamazaki T., Azuma M., Iwai H., Khoury S.J., et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198:2003;63-69
4. Ariyan C., Salvalaggio P., Fecteau S., Deng S., Rogozinski L., Mandelbrot D., Sharpe A., Sayegh M.H., Basadonna G.P., Rothstein D.M. Cutting edge. transplantation tolerance through enhanced CTLA-4 expression J. Immunol. 171:2003;5673-5677
5. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167:2001;1245-1253
6. Baroja M.L., Madrenas J. Viewpoint. therapeutic implications of CTLA-4 compartmentalization Am. J. Transplant. 3:2003;919-926
7. Bluestone J.A. Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol. 158:1997;1989-1993
8. Brunner M.C., Chambers C.A., Chan F.K., Hanke J., Winoto A., Allison J.P. CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162:1999;5813-5820
9. Carreno B.M., Collins M. The B7 family of ligands and its receptors. new pathways for costimulation and inhibition of immune responses Annu. Rev. Immunol. 20:2002;29-53
10. Carter L., Fouser L.A., Jussif J., Fitz L., Deng B., Wood C.R., Collins M., Honjo T., Freeman G.J., Carreno B.M. PD-1:pd-l inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 32:2002;634-643
11. Chapoval A.I., Ni J., Lau J.S., Wilcox R.A., Flies D.B., Liu D., Dong H., Sica G.L., Zhu G., Tamada K., Chen L. B7-H3. a costimulatory molecule for t cell activation and ifn-gamma production Nat. Immunol. 2:2001;269-274
12. Chitnis T., Najafian N., Abdallah K.A., Dong V., Yagita H., Sayegh M.H., Khoury S.J. CD28-independent induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 107:2001;575-583
13. Choi I.H., Zhu G., Sica G.L., Strome S.E., Cheville J.C., Lau J.S., Zhu Y., Flies D.B., Tamada K., Chen L. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J. Immunol. 171:2003;4650-4654
14. Coyle A.J., Gutierrez-Ramos J.C. The expanding B7 superfamily. increasing complexity in costimulatory signals regulating T cell function Nat. Immunol. 2:2001;203-209
15. Coyle A.J., Lehar S., Lloyd C., Tian J., Delaney T., Manning S., Nguyen T., Burwell T., Schneider H., Gonzalo J.A., et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 13:2000;95-105
16. Dong H., Chen L. B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 81:2003;281-287
17. Dong H., Zhu G., Tamada K., Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1999;1365-1369
18. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., et al. Tumor-associated B7-H1 promotes T-cell apoptosis. a potential mechanism of immune evasion Nat. Med. 8:2002;793-800
19. Dong H., Zhu G., Tamada K., Flies D.B., Van Deursen J.M., Chen L. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity. 20:2004;327-336
20. Fecteau S., Basadonna G.P., Freitas A., Ariyan C., Sayegh M.H., Rothstein D.M. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat. Immunol. 2:2001;58-63
21. Finger L.R., Pu J., Wasserman R., Vibhakar R., Louie E., Hardy R.R., Burrows P.D., Billips L.G. The human PD-1 gene. complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors Gene. 197:1997;177-187
22. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:2000;1027-1034
23. Gao W., Demirci G., Strom T.B., Li X.C. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation. 76:2003;994-999
24. Gavin M.A., Clarke S.R., Negrou E., Gallegos A., Rudensky A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3:2002;33-41
25. Griffin M.D., Hong D.K., Holman P.O., Lee K.M., Whitters M.J., O'Herrin S.M., Fallarino F., Collins M., Segal D.M., Gajewski T.F., et al. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152). J. Immunol. 164:2000;4433-4442
26. Griffin M.D., Holman P.O., Tang Q., Ashourian N., Korthauer U., Kranz D.M., Bluestone J.A. Development and applications of surface-linked single chain antibodies against T-cell antigens. J. Immunol. Methods. 248:2001;77-90
27. Harada H., Salama A.D., Sho M., Izawa A., Sandner S.E., Ito T., Akiba H., Yagita H., Sharpe A.H., Freeman G.J., Sayegh M.H. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J. Clin. Invest. 112:2003;234-243
28. Hatachi S., Iwai Y., Kawano S., Morinobu S., Kobayashi M., Koshiba M., Saura R., Kurosaka M., Honjo T., Kumagai S. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J. Rheumatol. 30:2003;1410-1419
29. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 397:1999;263-266
30. Ishida Y., Agata Y., Shibahara K., Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11:1992;3887-3895
31. Iwai Y., Terawaki S., Ikegawa M., Okazaki T., Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 198:2003;39-50
32. Kanai T., Totsuka T., Uraushihara K., Makita S., Nakamura T., Koganei K., Fukushima T., Akiba H., Yagita H., Okumura K., et al. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171:2003;4156-4163
33. Kantarci O.H., Hebrink D.D., Achenbach S.J., Atkinson E.J., Waliszewska A., Buckle G., McMurray C.T., de Andrade M., Hafler D.A., Weinshenker B.G. CTLA4 is associated with susceptibility to multiple sclerosis. J. Neuroimmunol. 134:2003;133-141
34. Karandikar N.J., Vanderlugt C.L., Walunas T.L., Miller S.D., Bluestone J.A. CTLA-4. a negative regulator of autoimmune disease J. Exp. Med. 184:1996;783-788
35. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., et al. PD-L2 is a second ligand for PD-I and inhibits T cell activation. Nat. Immunol. 2:2001;261-268
36. Lechner O., Lauber J., Franzke A., Sarukhan A., von Boehmer H., Buer J. Fingerprints of anergic T cells. Curr. Biol. 11:2001;587-595
37. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., Sharpe A.H. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33:2003;2706-2716
38. Loke P., Allison J.P. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc. Natl. Acad. Sci. USA. 100:2003;5336-5341
39. Luhder F., Hoglund P., Allison J.P., Benoist C., Mathis D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187:1998;427-432
40. Magistrelli G., Jeannin P., Herbault N., Benoit De Coignac A., Gauchat J.F., Bonnefoy J.Y., Delneste Y. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur. J. Immunol. 29:1999;3596-3602
41. Matsumoto K., Inoue H., Nakano T., Tsuda M., Yoshiura Y., Fukuyama S., Tsushima F., Hoshino T., Aizawa H., Akiba H., et al. B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. J. Immunol. 172:2004;2530-2541
42. McAdam A.J., Chang T.T., Lumelsky A.E., Greenfield E.A., Boussiotis V.A., Duke-Cohan J.S., Chernova T., Malenkovich N., Jabs C., Kuchroo V.K., et al. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4(+) T cells. J. Immunol. 165:2000;5035-5040
43. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., Freeman G.J., Sharpe A.H. ICOS is critical for CD40-mediated antibody class switching. Nature. 409:2001;102-105
44. Nielsen C., Hansen D., Husby S., Jacobsen B.B., Lillevang S.T. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens. 62:2003;492-497
45. Nishimura H., Minato N., Nakano T., Honjo T. Immunological studies on PD-1 deficient mice. implication of PD-1 as a negative regulator for B cell responses Int. Immunol. 10:1998;1563-1572
46. Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 11:1999;141-151
47. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai H., Minato N., Honjo T. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science. 291:2001;319-322
48. Oaks M.K., Hallett K.M., Penwell R.T., Stauber E.C., Warren S.J., Tector A.J. A native soluble form of CTLA-4. Cell. Immunol. 201:2000;144-153
49. Okazaki T., Maeda A., Nishimura H., Kurosaki T., Honjo T. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA. 98:2001;13866-13871
50. Okazaki T., Tanaka Y., Nishio R., Mitsuiye T., Mizoguchi A., Wang J., Ishida M., Hiai H., Matsumori A., Minato N., Honjo T. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med. 9:2003;1477-1483
51. Ozkaynak E., Wang L., Goodearl A., McDonald K., Qin S., O'Keefe T., Duong T., Smith T., Gutierrez-Ramos J.C., Rottman J.B., et al. Programmed death-1 targeting can promote allograft survival. J. Immunol. 169:2002;6546-6553
52. Prokunina L., Castillejo-Lopez C., Oberg F., Gunnarsson I., Berg L., Magnusson V., Brookes A.J., Tentler D., Kristjansdottir H., Grondal G., et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32:2002;666-669
53. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science. 290:2000;84-89
54. Rietz C., Chen L. New B7 family members with positive and negative costimulatory function. Am. J. Transplant. 4:2004;8-14
55. Rodriguez M.R., Nunez-Roldan A., Aguilar F., Valenzuela A., Garcia A., Gonzalez-Escribano M.F. Association of the CTLA4 3′ untranslated region polymorphism with the susceptibility to rheumatoid arthritis. Hum. Immunol. 63:2002;76-81
56. Rothstein D.M., Sayegh M.H. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol. Rev. 196:2003;85-108
57. Rottman J.B., Smith T., Tonra J.R., Ganley K., Bloom T., Silva R., Pierce B., Gutierrez-Ramos J.C., Ozkaynak E., Coyle A.J. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2:2001;605-611
58. Salama A.D., Chitnis T., Imitola J., Ansari M.J., Akiba H., Tushima F., Azuma M., Yagita H., Sayegh M.H., Khoury S.J. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198:2003;71-78
59. Salomon B., Rhee L., Bour-Jordan H., Hsin H., Montag A., Soliven B., Arcella J., Girvin A.M., Padilla J., Miller S.D., Bluestone J.A. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J. Exp. Med. 194:2001;677-684
60. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:2002;116-126
61. Shin T., Kennedy G., Gorski K., Tsuchiya H., Koseki H., Azuma M., Yagita H., Chen L., Powell J., Pardoll D., Housseau F. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. J. Exp. Med. 198:2003;31-38
62. Shinohara T., Taniwaki M., Ishida Y., Kawaichi M., Honjo T. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics. 23:1994;704-706
63. Shlapatska L.M., Mikhalap S.V., Berdova A.G., Zelensky O.M., Yun T.J., Nichols K.E., Clark E.A., Sidorenko S.P. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol. 166:2001;5480-5487
64. Sho M., Yamada A., Najafian N., Salama A.D., Harada H., Sandner S.E., Sanchez-Fueyo A., Zheng X.X., Strom T.B., Sayegh M.H. Physiological mechanisms of regulating alloimmunity. cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size J. Immunol. 169:2002;3744-3751
65. Sica G.L., Choi I.H., Zhu G., Tamada K., Wang S.D., Tamura H., Chapoval A.I., Flies D.B., Bajorath J., Chen L. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 18:2003;849-861
66. Stamper C.C., Zhang Y., Tobin J.F., Erbe D.V., Ikemizu S., Davis S.J., Stahl M.L., Seehra J., Somers W.S., Mosyak L. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature. 410:2001;608-611
67. Subudhi S.K., Zhou P., Yerian L.M., Chin R.K., Lo J.C., Anders R.A., Sun Y., Chen L., Wang Y., Alegre M.L., Fu Y.X. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113:2004;694-700
68. Suh W.K., Gajewska B.U., Okada H., Gronski M.A., Bertram E.M., Dawicki W., Duncan G.S., Bukczynski J., Plyte S., Elia A., et al. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 4:2003;899-906
69. Sun M., Richards S., Prasad D.V., Mai X.M., Rudensky A., Dong C. Characterization of mouse and human B7-H3 genes. J. Immunol. 168:2002;6294-6297
70. Sun X., Vale M., Leung E., Kanwar J.R., Gupta R., Krissansen G.W. Mouse B7-H3 induces antitumor immunity. Gene Ther. 10:2003;1728-1734
71. Tamura H., Ogata K., Dong H., Chen L. Immunology of B7-H1 and its roles in human diseases. Int. J. Hematol. 78:2003;321-328
72. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541-547
73. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193:2001;839-846
74. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., Rainbow D.B., Hunter K.M., Smith A.N., Di Genova G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:2003;506-511
75. Van Parijs L., Abbas A.K. Homeostasis and self-tolerance in the immune system. turning lymphocytes off Science. 280:1998;243-248
76. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., Bluestone J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:1994;405-413
77. Walunas T.L., Bakker C.Y., Bluestone J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:1996;2541-2550
78. Wang S., Zhu G., Chapoval A.I., Dong H., Tamada K., Ni J., Chen L. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood. 96:2000;2808-2813
79. Wang S., Bajorath J., Flies D.B., Dong H., Honjo T., Chen L. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197:2003;1083-1091
80. Watanabe N., Gavrieli M., Sedy J.R., Yang J., Fallarino F., Loftin S.K., Hurchla M.A., Zimmerman N., Sim J., Zang X., et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4:2003;670-679
81. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., Thompson C.B., Griesser H., Mak T.W. Lymphoproliferative disrorders with early lethality in mice deficient in Ctla-4. Science. 270:1995;985-988
82. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., Shin T., Tsuchiya H., Pardoll D.M., Okumura K., et al. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169:2002;5538-5545
83. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., Shih G., Zhang M., Coccia M.A., Kohno T., et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 402:1999;827-832
84. Zhang X., Schwartz J.C., Guo X., Bhatia S., Cao E., Chen L., Zhang Z.Y., Edidin M.A., Nathenson S.G., Almo S.C. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity. 20:2004;337-347